Renflexis Alternatives Compared
Renflexis | Simponi | Humira |
|
---|
Renflexis (infliximab) | Simponi (golimumab) | Humira (adalimumab) |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Crohn's Disease - Active, Ankylosing Spondylitis, Inflammatory Bowel Disease, Crohn's Disease, Plaque Psoriasis, Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, Ulcerative... View more |
Prescription only
Prescribed for Ankylosing Spondylitis, Psoriatic Arthritis, Rheumatoid Arthritis, Spondyloarthritis, Ulcerative Colitis. Simponi may also be used for purposes not listed in this medication guide. |
Prescription only
Humira is a TNF-alfa inhibitor that may be used to treat a wide range of different inflammatory conditions, such as Rheumatoid Arthritis, psoriasis, ankylosing spondylitis, Crohn's disease, and... View more |
Related suggestions Rheumatoid Arthritis
Psoriatic Arthritis
Ulcerative Colitis
Ankylosing Spondylitis
Popular comparisons
|
|||||||||||||||||||||||
More about Renflexis (infliximab) | More about Simponi (golimumab) | More about Humira (adalimumab) | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Renflexis has an average rating of 7.1 out of 10 from a total of 8 ratings on Drugs.com. 75% of reviewers reported a positive effect, while 25% reported a negative effect. |
Simponi has an average rating of 6.2 out of 10 from a total of 114 ratings on Drugs.com. 54% of reviewers reported a positive effect, while 30% reported a negative effect. |
Humira has an average rating of 6.3 out of 10 from a total of 679 ratings on Drugs.com. 54% of reviewers reported a positive effect, while 32% reported a negative effect. |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Side Effects | ||||||||||||||||||||||||||
See also: Renflexis side effects in more detail. |
See also: Simponi side effects in more detail. |
See also: Humira side effects in more detail. |
||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Renflexis prices |
View all Simponi prices |
View all Humira prices |
||||||||||||||||||||||||
Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
Other infliximab brands include: Avsola, Inflectra, Ixifi, Remicade, Zymfentra | Other golimumab brands include: Simponi Aria | Other adalimumab brands include: Abrilada, Amjevita, Cyltezo, Hadlima, Hulio, Hyrimoz, Idacio, Simlandi, Yuflyma, Yusimry View more | ||||||||||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
228 hours |
336 hours |
480 hours |
||||||||||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 498 drugs are known to interact with Renflexis:
|
A total of 480 drugs are known to interact with Simponi:
|
A total of 480 drugs are known to interact with Humira:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
N/A |
April 24, 2009 |
December 31, 2002 |
||||||||||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.